www.fdanews.com/articles/85957-psychogenics-and-sosei-partner-to-identify-new-cns-therapies
PSYCHOGENICS AND SOSEI PARTNER TO IDENTIFY NEW CNS THERAPIES
April 11, 2006
PsychoGenics Inc., Tarrytown, NY and Sosei Co. Ltd., Japan, have entered into
a drug discovery collaboration combining Sosei's Drug Reprofiling Platform and
PsychoGenics' proprietary Drug Discovery Systems. This collaboration aims to
rapidly discover and bring to market new CNS therapies.
PR
Newswire